Testicular cancer, although an uncommon malignancy, is the most frequently occurring cancer in young men. In the year 2009, an estimated 8,400 cases of testicular cancer will be diagnosed in the...
More »
A 24-year-old man presented to the emergency department with...
More »The first randomized trial to evaluate the long-term outcome of treatment with a single dose of chemotherapy for early-stage testicular tumors has found that the approach is safe, effective, and less...
More »MILAN—Some men with nonseminoma germ cell tumor (NSGCT) testicular cancer have a normalization of tumor markers and minimal or no residual masses in the retroperitoneum after chemotherapy. What then?...
More »High-dose combination chemotherapy followed by autologous peripheral-blood stem cell transplant produced durable remissions in metastatic testicular cancer patients who relapsed or failed to respond...
More »INDIANAPOLIS -- When metastatic testicular cancer progresses despite initial chemotherapy, including a cisplatin-based combination, a high-dose salvage regimen with stem-cell rescue can lead to...
More »Although testicular cancer is a rare disease accounting for only 1% of all male neoplasms, it represents a paradigm for cancer curability. Overall, more than 95% of patients can expect to be cured of...
More »Most testicular tumors are malignant and of germ-cell origin. They constitute only 1% of cancers in
males overall but are the most common malignant neoplasm in men aged 15 to 35 years. Testicular ...
More »Testicular cancer, although an uncommon malignancy, is the most frequently
occurring cancer in young men. In the year 2005, an estimated 8,010 cases of
testicular cancer will be diagnosed in the...
More »The management of germ cell tumors has advanced dramatically,
with cure rates approaching 90% to 95%. Treatment of stage I/A
seminomas generally includes orchiectomy and adjuvant radiotherapy....
More »
Showing 1 - 10 of 19 results.
